# Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09

> **NCT02235493** · — · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Hypophosphatasia
- Bone Disease

## Interventions

- **BIOLOGICAL:** Retrospective Case Only

## Key facts

- **NCT ID:** NCT02235493
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02235493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02235493, "Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02235493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*